Article: Ondine Biopharma Announces Third Quarter 2009 Financial Results.(Financial report)

VANCOUVER, BRITISH COLUMBIA, Nov 12, 2009 (Marketwire via COMTEX) -- Ondine Biopharma Corporation (the "Company" or "Ondine") (TSX:OBP)(AIM:OBP) a medical device company developing photodisinfection based products, today announced its financial results for the third quarter ended September 30, 2009.

"During the third quarter of 2009, we advanced several of our photodynamic product development initiatives, including an innovative cordless laser photodisinfection system with applications in both new medical and existing dental markets," said Carolyn Cross, Ondine's Chairman & CEO. "Subsequent to regulatory approval we expect to supply the new laser to Periowave ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!